ACADIA PHARMACEUTICALS INC. Inventory, Finished Goods, Gross
ACADIA PHARMACEUTICALS INC. (ACAD) had Inventory, Finished Goods, Gross of $1.16 million as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryFinishedGoods · last filed 2018-02-27
- 2017-12-31: Inventory, Finished Goods, Gross $1.16M.
- 2017-09-30: Inventory, Finished Goods, Gross $1.45M.
- 2017-06-30: Inventory, Finished Goods, Gross $1.92M.
- 2017-03-31: Inventory, Finished Goods, Gross $2.06M.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2017-12-31 | $1.16M 10-K · filed 2018-02-27 |
| 2017-09-30 | $1.45M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $1.92M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.06M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.35M 10-K · filed 2018-02-27 |
| 2016-09-30 | $2.16M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $723.00K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |